Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF671 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LANCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTF2H1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALDH3A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C16orf91 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NRBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NIPAL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TARDBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RANGAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSNK1G2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MPZL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT81 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2CB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASB8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on